Rekah Pharmaceutical Industry Ltd. (REKA.TA)
ILA 1400.0
(0.43%)
ILA 1400.0
(0.43%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -6.91 Million ILS | -238.23% |
| 2022 | -2.04 Million ILS | -130.84% |
| 2021 | 6.62 Million ILS | -38.65% |
| 2020 | 10.79 Million ILS | 291.91% |
| 2019 | 2.75 Million ILS | -60.79% |
| 2018 | 7.02 Million ILS | 131.26% |
| 2017 | -22.48 Million ILS | -104.36% |
| 2016 | -11 Million ILS | -149.21% |
| 2015 | -4.41 Million ILS | -781.04% |
| 2014 | -501 Thousand ILS | -106.02% |
| 2013 | 8.32 Million ILS | 12.39% |
| 2012 | 7.4 Million ILS | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 1.2 Million ILS | 233.19% |
| 2024 Q2 | 11.99 Million ILS | 899.92% |
| 2023 Q2 | -1.09 Million ILS | -289.77% |
| 2023 Q1 | 577 Thousand ILS | 123.76% |
| 2023 Q4 | -901 Thousand ILS | 83.59% |
| 2023 FY | -6.91 Million ILS | -238.23% |
| 2023 Q3 | -5.49 Million ILS | -401.46% |
| 2022 Q3 | 365 Thousand ILS | 170.6% |
| 2022 FY | -2.04 Million ILS | -130.84% |
| 2022 Q1 | 539 Thousand ILS | -83.76% |
| 2022 Q2 | -517 Thousand ILS | -195.92% |
| 2022 Q4 | -2.42 Million ILS | -765.21% |
| 2021 Q1 | 1.89 Million ILS | 0.91% |
| 2021 Q4 | 3.31 Million ILS | 6160.38% |
| 2021 Q3 | 53 Thousand ILS | -96.11% |
| 2021 FY | 6.62 Million ILS | -38.65% |
| 2021 Q2 | 1.36 Million ILS | -27.88% |
| 2020 Q2 | 2.36 Million ILS | -9.66% |
| 2020 Q1 | 2.62 Million ILS | 2398.25% |
| 2020 FY | 10.79 Million ILS | 291.91% |
| 2020 Q4 | 1.87 Million ILS | -52.43% |
| 2020 Q3 | 3.93 Million ILS | 66.33% |
| 2019 Q1 | 1.14 Million ILS | 275.74% |
| 2019 FY | 2.75 Million ILS | -60.79% |
| 2019 Q4 | -114 Thousand ILS | -105.32% |
| 2019 Q3 | 2.14 Million ILS | 163.02% |
| 2019 Q2 | 814 Thousand ILS | -28.97% |
| 2018 Q4 | 305 Thousand ILS | -78.41% |
| 2018 FY | 7.02 Million ILS | 131.26% |
| 2018 Q1 | 2.81 Million ILS | 137.71% |
| 2018 Q2 | 2.49 Million ILS | -11.38% |
| 2018 Q3 | 1.41 Million ILS | -43.32% |
| 2017 FY | -22.48 Million ILS | -104.36% |
| 2017 Q1 | -7.96 Million ILS | 48.94% |
| 2017 Q2 | -198 Thousand ILS | 97.51% |
| 2017 Q3 | -6.85 Million ILS | -3363.64% |
| 2017 Q4 | -7.46 Million ILS | -8.78% |
| 2016 Q2 | 1.96 Million ILS | 77.38% |
| 2016 FY | -11 Million ILS | -149.21% |
| 2016 Q1 | 1.1 Million ILS | -70.69% |
| 2016 Q4 | -15.59 Million ILS | -1118.68% |
| 2016 Q3 | 1.53 Million ILS | -21.89% |
| 2015 FY | -4.41 Million ILS | -781.04% |
| 2015 Q4 | 3.77 Million ILS | 158.04% |
| 2015 Q3 | 1.46 Million ILS | 185.99% |
| 2015 Q2 | -1.69 Million ILS | -98.02% |
| 2015 Q1 | -858 Thousand ILS | 85.93% |
| 2014 Q2 | 262 Thousand ILS | -86.56% |
| 2014 Q4 | -6.09 Million ILS | -544.21% |
| 2014 FY | -501 Thousand ILS | -106.02% |
| 2014 Q3 | 1.37 Million ILS | 424.05% |
| 2014 Q1 | 1.95 Million ILS | -11.24% |
| 2013 FY | 8.32 Million ILS | 12.39% |
| 2013 Q2 | 1.93 Million ILS | -10.71% |
| 2013 Q3 | 2.09 Million ILS | 8.17% |
| 2013 Q4 | 2.19 Million ILS | 5.02% |
| 2013 Q1 | 2.16 Million ILS | 196.31% |
| 2012 Q4 | 731 Thousand ILS | -10.96% |
| 2012 Q3 | 821 Thousand ILS | 0.0% |
| 2012 FY | 7.4 Million ILS | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Cannabotech LTD | -16.12 Million ILA | 57.139% |